Skip to main content
SpringerLink
Log in

Aflibercept/brolucizumab/ranibizumab

Lack of efficacy and intraocular inflammation: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Karmy BE, et al. Preventive Inflammation Management with Steroids before Retreatment with Anti-VEGF after Severe Inflammation due to Brolucizumab. Klinische Monatsblatter Fur Augenheilkunde 240: 556-562, No. 4, Apr 2023. Available from: URL: http://doi.org/10.1055/a-2045-7844 [Summarised from an abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aflibercept/brolucizumab/ranibizumab. Reactions Weekly 1961, 20 (2023). https://doi.org/10.1007/s40278-023-41277-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-41277-8

Search

Navigation